Tag: RE-CIRCUIT
ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation...
Results from the RE-CIRCUIT study have shown that uninterrupted dabigatran (Pradaxa, Boehringer Ingelheim), was associated with fewer bleeding complications than uninterrupted warfarin before, during...